2017
Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases
04/05/2017Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases Paris,... Read More
Damià Tormo Carulla, 2017 Princess of Girona Foundation Business Award
06/04/2017Damià Tormo Carulla, 2017 Princess of Girona Foundation Business Award Girona, Spain, April 6th 2017 - The winner was chosen for combining... Read More
Aura Biosciences Announces Initiation of Phase 1b Clinical Trial and Receipt of FDA Fast Track Designation for AU-011 for the Treatment of Primary Ocular Melanoma
30/03/2017Aura Biosciences Announces Initiation of Phase 1b Clinical Trial and Receipt of FDA Fast Track Designation for AU-011 for the Treatment... Read More
Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light-activated AU-011 for the Treatment of Ocular Melanoma
06/02/2017Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light-activated AU-011 for the Treatment of Ocular Melanoma Cambridge, USA,... Read More
Quirónsalud will establish the first center for proton therapy in Spain
04/01/2017Quirónsalud will establish the first center for proton therapy in Spain Madrid, Spain, 4th January 2017 - Quirónsalud, in its compromise... Read More